Matrix metalloproteinase-11 regulates inverted papilloma epithelial cell migration and invasion.
epithelial migration
inverted papilloma
matrix metalloproteinase‐11
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
05 Jul 2024
05 Jul 2024
Historique:
revised:
17
06
2024
received:
29
03
2024
accepted:
24
06
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
5
7
2024
Statut:
aheadofprint
Résumé
Inverted papilloma (IP) is a benign tumor characterized by epithelial proliferation, which has the potential for malignant transformation. However, the mechanisms driving this transformation are poorly defined. Matrix metalloproteinase-11 (MMP-11), a regulator of the tumor microenvironment that degrades extracellular matrix, is upregulated in IP with dysplasia. Here, we aim to investigate the role of MMP-11 in IP epithelial migration and invasion. Human IP and contralateral normal sinus mucosa (control) samples were obtained. IP-derived epithelial cultures and normal mucosa-derived epithelial cultures were grown in air‒liquid interface, followed by immunostaining to assess MMP-11 expression in IP. Migration and invasion assays were used to evaluate the role of an anti-MMP-11 antibody on IP and control epithelial cultures. IP-derived cultures demonstrated strong MMP-11 expression compared to controls. Treatment with anti-MMP-11 blocking antibody significantly reduced epithelial migration only in IP-derived cells compared to non-treated IP cells, as seen by incomplete wound closure and reduced transepithelial resistance. In addition, inhibition of MMP-11 reduced IP epithelia's ability to invade through collagen-coated transwells, suggesting that MMP-11 plays a role in invasion. We established an in vitro model to study IP-derived epithelial cells. MMP-11 is uniquely expressed in IP epithelial cultures compared to control epithelial cultures. Inhibition of MMP-11 limits IP epithelial migration and invasion to levels similar to that of normal sinus mucosa. MMP-11 does not appear to have a functional role in normal sinus epithelium, suggesting that MMP-11 has a role in malignant transformation of IP.
Sections du résumé
BACKGROUND
BACKGROUND
Inverted papilloma (IP) is a benign tumor characterized by epithelial proliferation, which has the potential for malignant transformation. However, the mechanisms driving this transformation are poorly defined. Matrix metalloproteinase-11 (MMP-11), a regulator of the tumor microenvironment that degrades extracellular matrix, is upregulated in IP with dysplasia. Here, we aim to investigate the role of MMP-11 in IP epithelial migration and invasion.
METHODS
METHODS
Human IP and contralateral normal sinus mucosa (control) samples were obtained. IP-derived epithelial cultures and normal mucosa-derived epithelial cultures were grown in air‒liquid interface, followed by immunostaining to assess MMP-11 expression in IP. Migration and invasion assays were used to evaluate the role of an anti-MMP-11 antibody on IP and control epithelial cultures.
RESULTS
RESULTS
IP-derived cultures demonstrated strong MMP-11 expression compared to controls. Treatment with anti-MMP-11 blocking antibody significantly reduced epithelial migration only in IP-derived cells compared to non-treated IP cells, as seen by incomplete wound closure and reduced transepithelial resistance. In addition, inhibition of MMP-11 reduced IP epithelia's ability to invade through collagen-coated transwells, suggesting that MMP-11 plays a role in invasion.
CONCLUSION
CONCLUSIONS
We established an in vitro model to study IP-derived epithelial cells. MMP-11 is uniquely expressed in IP epithelial cultures compared to control epithelial cultures. Inhibition of MMP-11 limits IP epithelial migration and invasion to levels similar to that of normal sinus mucosa. MMP-11 does not appear to have a functional role in normal sinus epithelium, suggesting that MMP-11 has a role in malignant transformation of IP.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : ARS Resident Research
Organisme : American Rhinologic Society
ID : Resident Core Grant #1060942
Informations de copyright
© 2024 The Author(s). International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.
Références
Kim JS, Kwon SH. Recurrence of sinonasal inverted papilloma following surgical approach: A meta‐analysis. Laryngoscope. 2017;127(1):52‐58. doi:10.1002/lary.26222
Bielamowicz S, Calcaterra TC, Watson D. Inverting papilloma of the head and neck: the UCLA update. Otolaryngol Head Neck Surg. 1993;109(1):71‐76. doi:10.1177/019459989310900113
Xiao‐Ting W, Peng L, Xiu‐Qing W, et al. Factors affecting recurrence of sinonasal inverted papilloma. Eur Arch Otorhinolaryngol. 2013;270(4):1349‐1353. doi:10.1007/s00405‐012‐2216‐z
Carta F, Blancal JP, Verillaud B, et al. Surgical management of inverted papilloma: approaching a new standard for surgery. Head Neck. 2013;35(10):1415‐1420. doi:10.1002/hed.23159
Tong CCL, Koptyra M, Raman P, et al. Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma. Int Forum Allergy Rhinol. 2022;12(2):200‐209. doi:10.1002/alr.22882
Kwon YJ, Hurst DR, Steg AD, et al. Gli1 enhances migration and invasion via up‐regulation of MMP‐11 and promotes metastasis in ERα negative breast cancer cell lines. Clin Exp Metastasis. 2011;28(5):437‐449. doi:10.1007/s10585‐011‐9382‐z
Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15(5):307. doi:10.1038/s41419‐024‐06697‐4
Zhang X, Huang S, Guo J, et al. Insights into the distinct roles of MMP‐11 in tumor biology and future therapeutics (review). Int J Oncol. 2016;48(5):1783‐1793. doi:10.3892/ijo.2016.3400
Lee J, Lee J, Kim JH. Identification of matrix metalloproteinase 11 as a prognostic biomarker in pancreatic cancer. Anticancer Res. 2019;39(11):5963‐5971. doi:10.21873/anticanres.13801
Zhuang Y, Li X, Zhan P, Pi G, Wen G. MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein. Oncol Rep. 2021;45(4):16. doi:10.3892/or.2021.7967
Hsin CH, Chou YE, Yang SF, et al. MMP‐11 promoted the oral cancer migration and Fak/Src activation. Oncotarget. 2017;8(20):32783‐32793. doi:10.18632/oncotarget.15824
Yang H, Jiang P, Liu D, et al. Matrix metalloproteinase 11 is a potential therapeutic target in lung adenocarcinoma. Mol Ther Oncolytics. 2019;14:82‐93. doi:10.1016/j.omto.2019.03.012
Pei D, Weiss SJ. Furin‐dependent intracellular activation of the human stromelysin‐3 zymogen. Nature. 1995;375(6528):244‐247. doi:10.1038/375244a0
O‐Charoenrat P, Rhys‐Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001;127(7):813‐820.
Soni S, Mathur M, Shukla NK, Deo SVS, Ralhan R. Stromelysin‐3 expression is an early event in human oral tumorigenesis. Int J Cancer. 2003;107(2):309‐316. doi:10.1002/ijc.11366
Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head Neck. 2006;28(7):639‐648. doi:10.1002/hed.20365
Ghosh B, Park B, Bhowmik D, et al. Strong correlation between air‒liquid interface cultures and in vivo transcriptomics of nasal brush biopsy. Am J Physiol Lung Cell Mol Physiol. 2020;318(5):L1056‐L1062. doi:10.1152/ajplung.00050.2020
Baldassi D, Gabold B, Merkel O. Air‒liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions. Adv Nanobiomed Res. 2021;1(6):2000111. doi:10.1002/anbr.202000111
Pezzulo AA, Starner TD, Scheetz TE, et al. The air‒liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L25‐L31. doi:10.1152/ajplung.00256.2010
Otter CJ, Fausto A, Tan LH, Khosla AS, Cohen NA, Weiss SR. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses. Proc Natl Acad Sci U S A. 2023;120(15):e2218083120. doi:10.1073/pnas.2218083120
Paranjapye A, Leir SH, Huang F, Kerschner JL, Harris A. Cell function and identity revealed by comparative scRNA‐seq analysis in human nasal, bronchial and epididymis epithelia. Eur J Cell Biol. 2022;101(3):151231. doi:10.1016/j.ejcb.2022.151231
Prescott RA, Pankow AP, de Vries M, et al. A comparative study of in vitro air‒liquid interface culture models of the human airway epithelium evaluating cellular heterogeneity and gene expression at single cell resolution. Respir Res. 2023;24(1):213. doi:10.1186/s12931‐023‐02514‐2
Zullo KM, Douglas B, Maloney NM, et al. LINGO3 regulates mucosal tissue regeneration and promotes TFF2 dependent recovery from colitis. Scand J Gastroenterol. 2021;56(7):791‐805. doi:10.1080/00365521.2021.1917650
Wise SK, Den Beste KA, Hoddeson EK, Parkos CA, Nusrat A. Sinonasal epithelial wound resealing in an in vitro model: inhibition of wound closure with IL‐4 exposure. Int Forum Allergy Rhinol. 2013;3(6):439‐449. doi:10.1002/alr.21158
Stoellinger HM, Alexanian AR. Modifications to the transwell migration/invasion assay method that eases assay performance and improves the accuracy. Assay Drug Dev Technol. 2022;20(2):75‐82. doi:10.1089/adt.2021.140
Nukpook T, Kiyono T, Ekalaksananan T, et al. An in vitro model and the underlying pathways of sinonasal inverted papilloma development. Sci Rep. 2023;13(1):18456. doi:10.1038/s41598‐023‐45585‐3
Nukpook T, Ekalaksananan T, Kiyono T, et al. Establishment and genetic characterization of cell lines derived from proliferating nasal polyps and sinonasal inverted papillomas. Sci Rep. 2021;11(1):17100. doi:10.1038/s41598‐021‐96444‐y
Barnes L. Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol. 2002;15(3):279‐297. doi:10.1038/modpathol.3880524
Bouchalova P, Bouchal P. Current methods for studying metastatic potential of tumor cells. Cancer Cell Int. 2022;22(1):394. doi:10.1186/s12935‐022‐02801‐w
Mittal R, Patel AP, Debs LH, et al. Intricate functions of matrix metalloproteinases in physiological and pathological conditions. J Cell Physiol. 2016;231(12):2599‐2621. doi:10.1002/jcp.25430
Jabłońska‐Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177‐183. doi:10.3109/14756366.2016.1161620
Martin‐Morales L, Manzano S, Rodrigo‐Faus M, et al. Germline gain‐of‐function MMP11 variant results in an aggressive form of colorectal cancer. Int J Cancer. 2023;152(2):283‐297. doi:10.1002/ijc.34289
Motrescu ER, Blaise S, Etique N, et al. Matrix metalloproteinase‐11/stromelysin‐3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene. 2008;27(49):6347‐6355. doi:10.1038/onc.2008.218
Jenkins MH, Alrowaished SS, Goody MF, Crawford BD, Henry CA. Laminin and matrix metalloproteinase 11 regulate Fibronectin levels in the zebrafish myotendinous junction. Skelet Muscle. 2016;6:18. doi:10.1186/s13395‐016‐0089‐3
Winkler J, Abisoye‐Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. doi:10.1038/s41467‐020‐18794‐x
Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278(1):16‐27. doi:10.1111/j.1742‐4658.2010.07919.x
Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990;348(6303):699‐704. doi:10.1038/348699a0
Bai L, Huo R, Fang G, Ma T, Shang Y. MMP11 is associated with the immune response and immune microenvironment in EGFR‐mutant lung adenocarcinoma. Front Oncol. 2023;13:1055122. doi:10.3389/fonc.2023.1055122
Hongo T, Yamamoto H, Jiromaru R, et al. Clinicopathologic significance of EGFR mutation and HPV infection in sinonasal squamous cell carcinoma. Am J Surg Pathol. 2021;45(1):108‐118. doi:10.1097/PAS.0000000000001566
Zonnur S, Erbersdobler A, Schneider B. EGFR and BRAF mutations in inverted sinonasal papilloma ‐ a more complex landscape? Virchows Arch. 2021;478(5):915‐924. doi:10.1007/s00428‐020‐02945‐y
Wang H, Li H, Hu L, et al. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma. Histopathology. 2019;75(2):274‐281. doi:10.1111/his.13868
Wassef SN, Batra PS, Barnett S. Skull base inverted papilloma: a comprehensive review. ISRN Surg. 2012;2012:175903. doi:10.5402/2012/175903
Eide JG, Welch KC, Adappa ND, Palmer JN, Tong CCL. Sinonasal inverted papilloma and squamous cell carcinoma: contemporary management and patient outcomes. Cancers (Basel). 2022;14(9):2195. doi:10.3390/cancers14092195
Tong CCL, Patel NN, Maina IW, et al. Inverted papilloma with multifocal attachment is associated with increased recurrence. Int Forum Allergy Rhinol. 2019;9(8):865‐869. doi:10.1002/alr.22342
Hadler‐Olsen E, Winberg JO, Uhlin‐Hansen L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol. 2013;34(4):2041‐2051. doi:10.1007/s13277‐013‐0842‐8
Butler GS, Overall CM. Updated biological roles for matrix metalloproteinases and new “intracellular” substrates revealed by degradomics. Biochemistry. 2009;48(46):10830‐10845. doi:10.1021/bi901656f
Overall CM, López‐Otín C. Strategies for MMP inhibition in cancer: innovations for the post‐trial era. Nat Rev Cancer. 2002;2(9):657‐672. doi:10.1038/nrc884
Fields GB. The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma. Cells. 2019;8(9):984. doi:10.3390/cells8090984
Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol Cancer Ther. 2018;17(6):1147‐1155. doi:10.1158/1535‐7163.MCT‐17‐0646